Online Database of Chemicals from Around the World
| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 2375281-44-8 | NF-kappaBeta activator 2 | C16H11FN2O3 |
| 2375281-56-2 | 3-[2-[(2-fluorophenyl)amino]-5-oxazolyl]-Benzoic acid methyl ester | C17H13N2O3F |
| 2375421-09-1 | SR-717 lithium | C15H8F2LiN5O3 |
| 2375865-91-9 | Rosuvastatin Impurity 18 | C15H26O6 |
| 2376271-49-5 | Tetratetraconta-4,17,21,27,40-pentaen-1,12,15,43-tetrayne-3,6,11,14,42-pentol | C44H64O5 |
| 2376271-61-1 | N-[7-[(Z)-1-(3-ethenyl-7-phenyl-1H-indol-2-yl)prop-1-enyl]-9H-fluoren-2-yl]-10-methyl-N-(4-phenylphenyl)-9,10-dihydrophenanthren-2-amine | C59H44N2 |
| 2376607-99-5 | Sugammadex Monohydroxy Impurity (7Na salt) | C69H101Na7O47S7 |
| 2376668-89-0 | Atomoxetine Impurity 8 | C18H21NO2 |
| 2376990-29-1 | Thalidomide-O-C4-NH2 (hydrochloride) | C17H20ClN3O5 |
| 2377545-66-7 | 9-Bromo-10-phenylanthracene-1,2,3,4,5,6,7,8-d8 | C20H5D8Br |
| 2377545-67-8 | 9-([1,1'-biphenyl]-4-yl)-10-bromoanthracene-1,2,3,4,5,6,7,8-d8 | C26H9D8Br |
| 2377545-68-9 | 9-Bromo-10-(phenyl-d5)anthracene-1,2,3,4,5,6,7,8-d8 | C20D13Br |
| 2377645-90-2 | 4-Chloro-3-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)benzoic acid | C11H9ClN2O4 |
| 2377770-18-6 | (2-(3,6-Dimethoxy-9H-carbazol-9-yl)ethyl)phosphonic acid | C16H18NO5P |
| 2378104-61-9 | 4-(5,6-dimethoxythieno[2,3-b]pyridin-2-yl)-4-oxobutanoic acid | C13H13NO5S |
| 2378104-86-8 | 2-Bromo-5.6-dimethoxynicotinaldehyde | C8H8BrNO3 |
| 2378356-17-1 | 2'-(9H-Carbazol-9-yl)-[1,1'-biphenyl]-4-amine | C24H18N2 |
| 2379325-42-3 | Duloxetine EP Impurity F | C18H19NOS .C2H2O4 |
| 2379402-85-2 | Bortezomib Impurity 5 | C19H22N4O4 |
| 2379460-04-3 | 9-Chloronaphtho[2,1-b]benzofuran | C16H9ClO |
| 2379694-79-6 | 1,10-Phenanthroline-3,8-dicarboxylic acid | C14H8N2O4 |
| 2379717-75-4 | 1-Chloro-8-phenyldibenzofuran | C18H11ClO |
| 2380027-49-4 | Src Inhibitor 3 | C34H32ClFN8O4 |
| 2380230-73-7 | 2-[2-[[3-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]phenyl]carbonylamino]phenyl]ethanoic acid | C27H29N3O3 |
| 2381089-83-2 | Retatrutide | C227H354N48O69 |
| 2381400-91-3 | 2-Methyl-2-propanyl (4S)-4-amino-3,3-difluoro-1-pyrrolidinecarboxylate | C9H16F2N2O2 |
| 2381627-87-6 | Carfilzomib Impurity 59 | C14H25NO4 |
| 2381854-90-4 | Fmoc-N-Me-3-(4-py)-L-Ala | C24H22N2O4 |
| 2382442-97-7 | Oseltamivir Impurity 207 | C12H18O4 |
| 2382664-60-8 | 4-Chloro-2-(morpholinomethyl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde | C19H18ClN3O4S |
| 2384108-14-7 | Cefazolin EP Impurity B | C16H20N4O4S3 |
| 2385124-34-3 | 3-bromo-5-fluoro-N-methylpyridin-2-amine | C6H6BrFN2 |
| 2387020-93-9 | Terbutaline Impurity 30 | C8H7BrO3 |
| 2387518-94-5 | 4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-2-fluoro-3-methylaniline | C13H11FN4O |
| 2387538-18-1 | 2-Chloro-4-neopentylpyridine | C10H14ClN |
| 2387728-91-6 | 1-[4-Ethoxy-3-(hydroxymethyl)phenyl]-2-[(2-methyl-2-propanyl)amino]ethanol | C15H25NO3 |
| 2389125-23-7 | Y6-BO-4F | C88H98F4N8O2S5 |
| 2389125-24-8 | BTP48C11-2CHO | C66H98N4O2S5 |
| 2392930-05-9 | 2-Chloro-4,6-di(dibenzofuran-1-yl)-1,3,5-triazine | C27H14ClN3O2 |
| 2395025-37-1 | Cefoxitin EP Impurity F | C17H19N3O8S2 |
| 2396570-49-1 | 2,4,6-Tris(4-(1H-pyrazol-4-yl)phenyl)-1,3,5-triazine | C30H21N9 |
| 2397634-28-3 | 1-N,1-N,3-N,3-N,5-N-pentakis-phenylbenzene-1,3,5-triamine | C36H29N3 |
| 2402776-83-2 | Baricitinib Impurity 24 | C16H17N7O2S |
| 2402776-84-3 | Baricitinib Impurity 16 | C23H27N9O4S2 |
| 2407527-16-4 | Enlicitide chloride | C82H110ClFN14O15 |
| 2407529-33-1 | (1R,3R)-1-[2,6-Difluoro-4-[[1-(3-fluoropropyl)-3-azetidinyl]amino]phenyl]-β,β-difluoro-1,3,4,9-tetrahydro-3-methyl-2H-pyrido[3,4-b]indole-2-propanol (2R,3R)-2,3-dihydroxybutanedioate (1:1) | C27H31F5N4O .C4H6O6 |
| 2407535-11-7 | 5-[[1-(3-Fluoropropyl)azetidin-3-yl]amino]pyridine-2-carbaldehyde | C12H16FN3O |
| 2408008-09-1 | 9-Phenyl-N-(2-phenylphenyl)carbazol-2-amine | C30H22N2 |
| 2408053-56-3 | Sacubitril Methyl Ester | C23H27NO5 |
| 2408294-08-4 | Methanesulfonato 1,1'-Bis(di-tert-butylphosphino) ferrocene (2'-amino-1,1'-biphenyl-2-yl) palladium(II) | C39H49FeNO3P2PdS |